|
GTB-360 Clinical Trials
1 actively recruiting trial across 1 location
Also known as: anti-CD16/IL-15/anti-CD33
Minneapolis, Minnesota1 trial
HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML
Masonic Cancer Center
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.